Research Grant
[Cite as https://purl.org/au-research/grants/arc/LX0346972]Researchers: Nicholas Farrell (Chief Investigator) , Sue Berners-Price (Chief Investigator)
Brief description NMR studies on DNA interactions of polynuclear platinum. BBR3464 is representative of a class of structurally unique platinum anticancer drugs, and is currently undergoing clinical trials. The anticancer activity most likely depends on binding to DNA, but the mechanism is different from that of the widely used drug, cisplatin. This project uses NMR spectroscopy to follow in detail the stepwise formation of DNA adducts. Further extension to reactions of polynuclear platinum complexes with sulfur nucleophiles will aid in understanding their metabolism and toxicity. The results of this work will aid in the selection of back-up clinical candidates and the design of drugs that target specific sequences of DNA for use in novel gene-based therapies.
Funding Amount $32,000
Funding Scheme Linkage - International
- PURL : https://purl.org/au-research/grants/arc/LX0346972
- ARC : LX0346972